(R)-1-(4-Chloro-3-fluorophenyl)ethanaminehydrochloride, 95.0%, 100mg

Dimethyl 2-(5-chloro-3-nitropyridin-2-yl)malonate, 95.0%, 5g

7-Chloro-1H-pyrido[3,4-b][1,4]oxazin-2(3H)-one, 95.0%, 500mg

Ethyl 2-(5-chloro-2-methyl-1H-indol-3-yl)acetate, 97%, 1g

Diethyl (2-Oxopropyl)phosphonate>95.0%(GC)25g

Viscosity standard S3, ROTI®Calipure, 4.5 cSt (20 °C), 500 ml, glass packaging

Methyl 4-bromo-2-fluoro-5-nitrobenzoate, 97.0%, 5g

Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate, 98%, 250mg

Omipalisib, 99.93%, 100mg

Ethyl 2-formylthiophene-3-carboxylate, 95.0%, 50mg

ethyl 4-hydroxy-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylate, 95.0%, 250mg

Tetrabutylammonium iodide, 98.0%, 1g

2-Nitro-4-(trifluoromethyl)benzoic Acid>98.0%(GC)(T)25g